ISPC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
iSpecimen Inc (ISPC) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators show a bearish trend, the financial performance is extremely poor, and there are no positive catalysts or trading signals to suggest a potential upside. The stock's outlook is negative, and the risk outweighs the potential reward in this scenario.
The MACD is negative and expanding downward (-0.00027), indicating bearish momentum. The RSI (39.91) is neutral but leaning toward oversold territory. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key support levels (S1: 0.295). The stock has a 70% chance to decline further (-0.07% next day, -0.81% next week, -11.11% next month).
NULL identified. No significant trading trends from hedge funds or insiders. No recent congress trading data.
The company's financials are extremely weak, with a 96% YoY revenue drop in Q3 2025, a negative gross margin (-92.05%), and a significant EPS decline (-77.14% YoY). Technical indicators suggest a bearish outlook, and the stock is expected to decline further in the short and long term.
In Q3 2025, revenue dropped by 96% YoY to $106,592. Net income improved but remains negative at -$2,780,648 (up 93.12% YoY). EPS fell to -0.48 (-77.14% YoY), and gross margin dropped significantly to -92.05% (-321.27% YoY). Overall, the company's financial performance is extremely poor.
No analyst ratings or price target changes were provided. Wall Street sentiment is neutral to negative due to poor financial performance and lack of positive catalysts.
